Literature DB >> 27435502

The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.

Gloria Bertoli1, Claudia Cava1, Isabella Castiglioni1.   

Abstract

Dysregulation of microRNAs (miRNAs) has a fundamental role in the initiation, development and progression of several human cancers, including breast cancer (BC), since strong evidence has shown that miRNAs can regulate the expression of oncogenes or tumor suppressor genes. A possible role of miRNAs in the diagnosis in BC has been demonstrated. As miRNAs has been found stable in biofluids, extracellular multiple miRNA profiles have been proposed as diagnostic tools, showing better diagnostic performance than individual miRNAs in BC. In this paper, based on the current literature, we present the role of microRNAs in the diagnosis and therapy monitoring of BC. Furthermore, we report new miRNA-based drugs that could be turned into promising therapy for BC, alone or in combination with conventional therapy. We also discuss how extracellular miRNAs could become new, easily accessible, affordable, non-invasive tools for BC patients.

Entities:  

Keywords:  Biomarkers; breast cancer; microRNA/miRNAs

Mesh:

Substances:

Year:  2016        PMID: 27435502     DOI: 10.1080/00365513.2016.1208444

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest Suppl        ISSN: 0085-591X


  14 in total

1.  Clinical significance of miR-181a in patients with neonatal sepsis and its regulatory role in the lipopolysaccharide-induced inflammatory response.

Authors:  Guozhi Liu; Wei Liu; Jie Guo
Journal:  Exp Ther Med       Date:  2020-01-02       Impact factor: 2.447

2.  miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.

Authors:  Dengfeng Li; Jiashu Hu; Hongming Song; Hui Xu; Chengyang Wu; Bingkun Zhao; Dan Xie; Tianqi Wu; Junyong Zhao; Lin Fang
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

3.  A feedback loop consisting of RUNX2/LncRNA-PVT1/miR-455 is involved in the progression of colorectal cancer.

Authors:  Jie Chai; Dawei Guo; Wanli Ma; Dali Han; Wei Dong; Hongliang Guo; Yi Zhang
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

4.  Limonoid compounds from Xylocarpus granatum and their anticancer activity against esophageal cancer cells.

Authors:  Li Jing; Li Feng; Zhiguo Zhou; Shuai Shi; Ruoying Deng; Zhicong Wang; Yibing Liu
Journal:  Thorac Cancer       Date:  2020-05-25       Impact factor: 3.500

5.  miRNA deregulation targets specific pathways in leiomyosarcoma development: an in silico analysis.

Authors:  Clara Benna; Senthilkumar Rajendran; Marco Rastrelli; Simone Mocellin
Journal:  J Transl Med       Date:  2019-05-14       Impact factor: 5.531

Review 6.  MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.

Authors:  Maria Anna Smolle; Andreas Leithner; Florian Posch; Joanna Szkandera; Bernadette Liegl-Atzwanger; Martin Pichler
Journal:  Int J Mol Sci       Date:  2017-09-12       Impact factor: 5.923

7.  Novel regulation of miR-34a-5p and HOTAIR by the combination of berberine and gefitinib  leading to inhibition of EMT in human lung cancer.

Authors:  Fang Zheng; Jing Li; ChangJu Ma; XiaoJuan Tang; Qing Tang; JingJing Wu; XiaoSu Chai; Jianhui Xie; Xiao-Bo Yang; Swei Sunny Hann
Journal:  J Cell Mol Med       Date:  2020-04-05       Impact factor: 5.310

8.  MicroRNA‑424 serves an anti‑oncogenic role by targeting cyclin‑dependent kinase 1 in breast cancer cells.

Authors:  Dan Xie; Hongming Song; Tianqi Wu; Dengfeng Li; Kaiyao Hua; Hui Xu; Bingkun Zhao; Chenyang Wu; Jiashu Hu; Changle Ji; Yijun Deng; Lin Fang
Journal:  Oncol Rep       Date:  2018-09-27       Impact factor: 3.906

9.  Inactivation of Stat3 and crosstalk of miRNA155-5p and FOXO3a contribute to the induction of IGFBP1 expression by beta-elemene in human lung cancer.

Authors:  Fang Zheng; Qing Tang; Xiao-Hua Zheng; JingJing Wu; HaiDing Huang; Haibo Zhang; Swei Sunny Hann
Journal:  Exp Mol Med       Date:  2018-09-12       Impact factor: 8.718

10.  Portrait of Tissue-Specific Coexpression Networks of Noncoding RNAs (miRNA and lncRNA) and mRNAs in Normal Tissues.

Authors:  Claudia Cava; Gloria Bertoli; Isabella Castiglioni
Journal:  Comput Math Methods Med       Date:  2019-09-03       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.